Compare Becton Dickinson and Co (BDX) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Vipshop Holdings Ltd - ADR — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $41.51B), while Vipshop Holdings Ltd - ADR trades at $13.43 (market cap $6.66B). The key difference: Becton Dickinson and Co is far larger — about 6.2× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays the higher dividend (4.47%). Which is the better fit depends on your goals.
| BDX | VIPS | |
|---|---|---|
Market Cap | $41.51B | $6.66B |
Sector | Health | Consumer Cyclical |
52-Week High | $185.39 | $20.68 |
52-Week Low | $135.49 | $12.92 |
Enterprise Value | $57.97B | $3.25B |
Dividend Yield | 2.79% | 4.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
Vipshop Holdings (VIPS) trades at $13.92, down slightly by 0.14% on the day, with a bullish technical signal supported by strong ADX readings. The stock presents attractive valuation metrics with a P/E of 6.35 and P/S of 0.45, while maintaining solid profitability with an 18.43% ROE. Recent Q1 2026 earnings matched expectations, and the company is pursuing growth through outlet store spin-offs into a REIT structure.
The outlook remains positive given deep value multiples and analyst consensus leaning buy, though risks include revenue pressure from a later Chinese New Year and competitive e-commerce headwinds. Upside potential hinges on execution of the outlet strategy and return to sustained revenue growth in FY2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
